Cubic Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.53M | Buy |
20,867
+365
| +2% | +$28.1K | 0.36% | 71 |
|
|
2023
Q4 | $1.66M | Sell |
20,502
-120
| -0.6% | -$9.34K | 0.43% | 67 |
|
|
2023
Q3 | $1.55M | Sell |
20,622
-175
| -0.8% | -$13.5K | 0.43% | 66 |
|
|
2023
Q2 | $1.6M | Hold |
20,797
| – | – | 0.43% | 63 |
|
|
2023
Q1 | $1.73M | Sell |
20,797
-475
| -2% | -$39.3K | 0.48% | 59 |
|
|
2022
Q4 | $1.83M | Buy |
21,272
+461
| +2% | +$36.5K | 0.52% | 56 |
|
|
2022
Q3 | $1.28M | Buy |
20,811
+18
| +0.1% | +$1.14K | 0.38% | 67 |
|
|
2022
Q2 | $1.28M | Sell |
20,793
-400
| -2% | -$24.8K | 0.35% | 74 |
|
|
2022
Q1 | $1.26M | Buy |
21,193
+225
| +1% | +$14.4K | 0.29% | 77 |
|
|
2021
Q4 | $1.52M | Sell |
20,968
-20
| -0.1% | -$1.38K | 0.34% | 71 |
|
|
2021
Q3 | $1.47M | Sell |
20,988
-830
| -4% | -$58.3K | 0.36% | 68 |
|
|
2021
Q2 | $1.5M | Sell |
21,818
-118
| -0.5% | -$7.88K | 0.37% | 66 |
|
|
2021
Q1 | $1.42M | Sell |
21,936
-405
| -2% | -$26.1K | 0.37% | 68 |
|
|
2020
Q4 | $1.3M | Sell |
22,341
-932
| -4% | -$56.2K | 0.39% | 65 |
|
|
2020
Q3 | $1.47M | Sell |
23,273
-2,413
| -9% | -$167K | 0.53% | 54 |
|
|
2020
Q2 | $1.98M | Sell |
25,686
-150
| -0.6% | -$11.5K | 0.71% | 50 |
|
|
2020
Q1 | $1.93M | Buy |
25,836
+1,090
| +4% | +$75.3K | 0.78% | 48 |
|
|
2019
Q4 | $1.61M | Sell |
24,746
-6,985
| -22% | -$455K | 0.45% | 63 |
|
|
2019
Q3 | $2.01M | Buy |
31,731
+10
| +0% | +$654 | 0.6% | 54 |
|
|
2019
Q2 | $2.14M | Sell |
31,721
-1,066
| -3% | -$70.1K | 0.64% | 51 |
|
|
2019
Q1 | $2.13M | Sell |
32,787
-1,395
| -4% | -$92.7K | 0.63% | 53 |
|
|
2018
Q4 | $2.14M | Sell |
34,182
-3,245
| -9% | -$227K | 0.7% | 51 |
|
|
2018
Q3 | $2.89M | Buy |
37,427
+6,455
| +21% | +$488K | 0.79% | 49 |
|
|
2018
Q2 | $2.19M | Sell |
30,972
-795
| -3% | -$56.1K | 0.63% | 51 |
|
|
2018
Q1 | $2.4M | Sell |
31,767
-508
| -2% | -$40.4K | 0.68% | 51 |
|
|
2017
Q4 | $2.31M | Buy |
32,275
+2,049
| +7% | +$156K | 0.64% | 54 |
|
|
2017
Q3 | $2.45M | Sell |
30,226
-560
| -2% | -$42.8K | 0.69% | 53 |
|
|
2017
Q2 | $2.18M | Buy |
30,786
+1,085
| +4% | +$72.2K | 0.64% | 52 |
|
|
2017
Q1 | $2.02M | Buy |
29,701
+560
| +2% | +$39.4K | 0.61% | 53 |
|
|
2016
Q4 | $2.09M | Sell |
29,141
-355
| -1% | -$26.4K | 0.64% | 51 |
|
|
2016
Q3 | $2.33M | Buy |
29,496
+275
| +0.9% | +$22.3K | 0.75% | 48 |
|
|
2016
Q2 | $2.44M | Buy |
29,221
+4,071
| +16% | +$361K | 0.83% | 47 |
|
|
2016
Q1 | $2.31M | Buy |
25,150
+520
| +2% | +$46.9K | 0.78% | 48 |
|
|
2015
Q4 | $2.49M | Buy |
24,630
+1,550
| +7% | +$161K | 0.86% | 44 |
|
|
2015
Q3 | $2.27M | Buy |
23,080
+1,130
| +5% | +$126K | 0.8% | 46 |
|
|
2015
Q2 | $2.57M | Sell |
21,950
-2,475
| -10% | -$270K | 0.82% | 49 |
|
|
2015
Q1 | $2.4M | Buy |
+24,425
| New | +$2.48M | 0.77% | 51 |
|
Other funds holding GILD
Cubic Asset Management's GILD Position: Q1 2024 in Review
Cubic Asset Management increased its Gilead Sciences (GILD) stake by 1.8% in Q1 2024, buying an estimated $28.1K and bringing the position to 20,867 shares worth $1.53M. The position accounts for 0.36% of the portfolio, ranked #71.
Cubic Asset Management first reported a position in GILD in Q1 2015 and has held it in 37 quarters since. The position peaked at $2.89M in Q3 2018. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Cubic Asset Management held 20,867 shares of Gilead Sciences worth $1.53M as of Q1 2024.
- Cubic Asset Management bought 365 Gilead Sciences shares in Q1 2024, an estimated $28.1K.
- Gilead Sciences made up 0.36% of Cubic Asset Management's portfolio in Q1 2024, its #71 holding.
- Cubic Asset Management first reported a position in Gilead Sciences in Q1 2015 and has held it in 37 quarters since.
- Cubic Asset Management's Gilead Sciences position peaked at $2.89M in Q3 2018.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.